Wednesday, April 28, 2010
Several small studies had previously suggested that insulin sensitizers and antioxidants might alter the progression of the disease. Research enrolled with 247 adults with the disease but without diabetes, dividing them into three groups. One group received 800 international units of vitamin E daily, the second received the diabetes drug pioglitazone and the third received a placebo. It was the largest clinical trial ever conducted for treating the disease.
Journal of Medicine reported 43% of the patients receiving vitamin E showed a major improvement in liver function, compared with 19% of those who received either placebo or pioglitazone. Pioglitazone reduced liver inflammation and improved retention of lipids in 34% of the individual receiving it, but the improvements were not statistically significant. But those taking the diabetes drug also had a 10-pound weight gain.
posted by emedinfo
@11:12 PM
permanent link |
|
| Bookmark & Share |
|
|
<< Home